NLS Pharmaceutics Ltd. Warrant

YTD

ALL

Why Robinhood?

You can watch NLSPW and buy or sell other stocks, ETFs, and their options commission-free!

About NLSPW

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder.

CEO

Alexander C. Zwyer, EMBA

CEOAlexander C. Zwyer, EMBA

Employees

—

Employees—

Headquarters

Zurich, Zurich

HeadquartersZurich, Zurich

Founded

2015

Founded2015

Employees

—

Employees—

NLSPW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

68.68K

Average volume68.68K

High today

$0.0096

High today$0.0096

Low today

$0.0042

Low today$0.0042

Open price

$0.0042

Open price$0.0042

Volume

43.03K

Volume43.03K

52 Week high

$0.0698

52 Week high$0.0698

52 Week low

$0.0009

52 Week low$0.0009